During the past decade, Hospital Infanta Cristina conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 12 clinical trials were completed, i.e. on average, 38.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Infanta Cristina" #1 sponsor was "Spanish Breast Cancer Research Group" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Infanta Cristina" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator, "AECC_Asociación Española contra el Cáncer" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Infanta Cristina" are "Breast Cancer" (8 trials), "Coronary Artery Disease" (4 trials), "Breast Neoplasms" (2 trials), "Ischemic Heart Disease" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Hospital Infanta Cristina" in a lesser frequency.

Most popular intervention types in "Hospital Infanta Cristina" are "Drug" (27 trials), "Device" (7 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Capecitabine" (2 trials), "Fulvestrant" (2 trials), "Lapatinib" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Infanta Cristina" are 39 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Infanta Cristina". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Hospital Infanta Cristina, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Infanta Cristina, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".